The global technology industry experienced a 37% decline in the number of Covid-19-related patent applications in Q3 2023 compared with the previous quarter. The total number of Covid-19-related grants dropped by 42% in Q3 2023, according to GlobalData’s Patent Analytics. GlobalData’s databook Technology: Patents Trends Q3 2023 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years. Buy the databook here.
Notably, the number of Covid-19-related patent applications in the technology industry was 97 in Q3 2023, versus 154 in the prior quarter.
The top five companies accounted for 8% of patenting activity
Analysis of patenting activity by companies shows that Metro International Biotech filed the most Covid-19 patents within the technology industry in Q3 2023. The company filed 2 Covid-19-related patents in the quarter. It was followed by General Hospital with 2 Covid-19 patent filings, Fujifilm (2 filings), and University of California (1 filing) in Q3 2023.
Patenting activity was driven by the US with a 56% share of total patent filings
The largest share of Covid-19 related patent filings in the technology industry in Q3 2023 was in the US with 56%, followed by China (19%) and South Korea (9%). The share represented by the US was 6% higher than the 49% share it accounted for in Q2 2023.
For further understanding of GlobalData's Technology: Patents Trends Q3 2023, buy the databook here.